F Dx Advisors, Inc. Astrazeneca PLC Transaction History
F Dx Advisors, Inc.
- $308 Million
- Q1 2025
A detailed history of F Dx Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, F Dx Advisors, Inc. holds 11,420 shares of AZN stock, worth $841,425. This represents 0.27% of its overall portfolio holdings.
Number of Shares
11,420
Previous 12,141
5.94%
Holding current value
$841,425
Previous $795,000
5.53%
% of portfolio
0.27%
Previous 0.23%
Shares
34 transactions
Others Institutions Holding AZN
# of Institutions
1,433Shares Held
507MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.21 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$3 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.63 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.35 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.31 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...